A BRAWL OVER PRESCRIPTION DATA

摘要

IMS Health has built a lucrative niche collecting data on which drugs physicians prescribe, then selling the information to pharmaceutical companies. But legislators in more than 20 states are considering actions to curb the practices. The Supreme Court could shine a spotlight on this topic in the next few weeks if it decides to hear a closely watched case IMS has been fighting in New Hampshire. The court's ruling would quickly reverberate beyond the pharmaceutical indus -try, affecting virtually any businessrnthat uses information about consumer buying behavior.